In the October issue, we published an article about the results of a meta-analysis reported at ASCO 2012 that supported the new guidelines that recommend weight-based chemotherapy dosing for obese cancer patients. We asked our online reading community if they had experience with dosing for obese patients.
- 89% have dealt with weight-based dosing, with 1 reader commenting “every day”
- 11% have not had experience with dosing for obese patients
Our sincere thanks to all who participated in this survey.
If you want to participate in the new survey, see page 8 for details.